Blue Horseshoe Stocks: DMPI Recap & More

Del Mar Pharmaceuticals, Inc . DMPI

We wanted to swing back around to recap the solid performance of DMPI since we tagged it the day after the Christmas break a couple of weeks back.

It was just a couple sessions later that the stock would find support at .96, and begin a pretty substantial run up the chart. It was helped along by the last six consecutive sessions registering higher base levels of support as the stock has crept all the way up to a high of 1.75, recorded on Friday.

That worked out to a move of 82% in less than two trading weeks, while volume over the same period has been heightened. The high coincided with the current 200DMA, so we’ll look for DMPI to possibly crack that 1.75 mark and head for blue skies.

Kohls Corp KSS

We want to include an options idea for Kohls as we kick off the first full trading week of 2018, on the heels of a solid earnings report.

The company posted strong sales for the holiday season, while giving a significant boost to full year guidance. Shares jumped accordingly in premarket trading, and we are going to be waiting with some targeted weekly contracts to coincide with the activity. We’re going to signal and track the KSS Weekly $58-60 Calls.

Extended Watchlist:

Blue Horseshoe Stocks: DE Options Recap & More

Urban Outfitters, Inc. URBN – Options Rehash

We have been hitting one home run after another with our options ideas recently, and kept the trend going on Wednesday before the holiday break. We offered up the Deere & Co. DE Weekly $143-146 Calls as a fresh idea for the day in our premarket report, and it turned out to be another good one.

All but one of the contracts contained within our highlighted range recorded single-session gains exceeding two hundred percent!

DE Weekly $143-146 Calls
$143 Calls –
Range:  .82-2.50 – Max Gain: 205%
$144 Calls – Range:  .50-1.53 – Max Gain: 206%
$145 Calls – Range:  .30-1.00 – Max Gain: 233%
$146 Calls – Range: .19-.53 – Max Gain: 220%

From the looks of things this morning , we could actually end up seeing these ranges extended even further. Just be aware that the normal extreme risk associated with trading weekly options on a Friday is heightened even more in a half-day scenario like today.

General Electric Co. GE – More Options Ideas

We’ve been watching GE try to find a bottom for more than a month now, and finally, we’ve got a coupls solid signals that this could be the moment we were waiting for. Not only did the stock make a moderate rebound off of its newly-registered 52-week lows, but we’ve also noticed an enormous tranche of insider buying.

An order for 3M shares was executed earlier this week in the amount of roughly $53M. You don’t generally tend to see that kind of money sunk into a stock by someone in-the-know, unless they’re fairly certain that the current support will hold.

As a result, we are going to signal a range of options ideas here as well for a longer-term recovery play, with the targets being the GE 01/19 $18-19 Calls.

Extended Watchlist:

Blue Horseshoe Stocks: Bottom Play Friday

NewLead, Ltd. NEWL

We’ve been tracking NEWL for a long time, waiting for the stock to find support and bounce up off of a bottom, and that appears to have happened now. Since the last time we touched base with this play on April 17th, it had consolidated all the way down from the .20′s to less than a nickel.

Yesterday we saw a surge back into the six cent range, so we want to make note of this stock again today, monitor for higher lows and higher highs, and try to take advantage if NEWL continues to rebound.

Prima BioMed, Ltd. PBMD

Here’s another stock that has been trading at a relative bottom, that just put out FDA fast-track news this morning. PBMD is gapping up into the 1.20′s this morning after its big announcement, so this presents us with an interesting and familiar scenario.

Due to the nature of the fresh PR, and the fact that a large gap-up appears imminent, we’re going to have this play on close watch for a dip-and-rip. For our new readers, this is when a significant event drives a stock to gap up, and the resultant profit-taking drives the price back down. It’s there that we attempt to time the bottom and score quick-strike profits on the bounce. Over the years, this has become one of our favorite methods of obtaining rapid in-and-out gains.

SYDNEY, AUSTRALIA–(Marketwired – May 9, 2014) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima”) is pleased to announce today that the United States Food and Drug Administration (“FDA”) granted Fast Track Designation to the CVac clinical development program at Prima. This program is intended to improve overall survival in patients with relapsed platinum-sensitive epithelial ovarian cancer who enter a second complete remission. Prima will work closely with the FDA in accelerating its development program for CVac to potentially bring this treatment option to patients in the U.S. >>> FULL PR

OBJ Enterprises, Inc. OBJE

OBJE hit our news scanner this morning, and it caused us to take notice of the chart. The stock has been in a continuous downtrend since early this year, so we’re going to go ahead and put this on bottom-watch.

It’s already trading at its annual lows, we’ll just be monitoring for when it does reach an eventual base, where we’ll be waiting to scoop up cheap shares and play the recovery.

HOUSTON–(BUSINESS WIRE)–OBJ Enterprises, Inc. (OBJE) and partner My Go Games LLC (GO) are proud to announce how its growing portfolio of brands will serve as a catalyst and delivery portal as we prepare for multiple game releases in 2014.

My Go Games and OBJE plan to combine strategies that leverage product placement and established brand networks that utilize social, mobile and online platforms to deliver revenue generating games and product sales channels to a booming marketplace. >>> FULL PR

Side Note:

PBR earnings are slated for release today, which could lead to significant volatility. We’ll still be monitoring the same Calls we’ve tracked all week, while staying ready to switch up our strategy should the need arise, dictated by the nature of the figures.

Extended Watchlist: